DP00748: Adapter molecule crkFASTA viewXML view

General information
DisProt:DP00748
Name:Adapter molecule crk
Synonym(s):CRK_HUMAN
Proto-oncogene c-Crk
p38
CrkII or CRKII
Crk-II
[Crk-I is Isoform 2, see DP00748_A002]
First appeared in release:Release 6.02 (05/24/2013)
UniProt:P46108
UniGene:Hs.461896
SwissProt: CRK_HUMAN
TrEMBL:  
NCBI (GI):  
Source organism:Homo sapiens (Human)
Sequence length:304
Percent disordered:51%
Homologues: 


Native sequence

        10         20         30         40         50         60
         |          |          |          |          |          |
MAGNFDSEER SSWYWGRLSR QEAVALLQGQ RHGVFLVRDS STSPGDYVLS VSENSRVSHY - 60
IINSSGPRPP VPPSPAQPPP GVSPSRLRIG DQEFDSLPAL LEFYKIHYLD TTTLIEPVSR - 120
SRQGSGVILR QEEAEYVRAL FDFNGNDEED LPFKKGDILR IRDKPEEQWW NAEDSEGKRG - 180
MIPVPYVEKY RPASASVSAL IGGNQEGSHP QPLGGPEPGP YAQPSVNTPL PNLQNGPIYA - 240
RVIQKRVPNA YDKTALALEV GELVKVTKIN VSGQWEGECN GKRGHFPFTH VRLLDQQNPD - 300
EDFS



Functional narrative    

Adapter molecule crk is a proto-oncogene existing in two isoforms, Crk-II and Crk-I. Crk-II is the UniProt canonical sequence [DP00748], comprising aa 1-304. Crk-I is UniProt alternatively-spliced product 2 [DP00748_A002], comprising aa 1-204 of canonical sequence and including a variation at N204R.
------------------------------------------------------------------------------------------------------------------
"CRK regulates transcription and cytoskeletal reorganization during cell growth, motility, proliferation, adhesion, differentiation and apoptosis by acting as an adaptor to link tyrosine kinases and small G proteins. CRKI (SH2-SH3) and CRKII (SH2-SH3-SH3) are splicing isoforms of the oncoprotein CRK." (Kobashigawa et al, 2007, and references therein)
------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------
From UniProt: The Crk-I and Crk-II forms differ in their biological activities. Crk-II has less transforming activity than Crk-I. Crk-II mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4. May regulate the EFNA5-EPHA3 signaling.
------------------------------------------------------------------------------------------------------------------
Copyright The UniProt Consortium, http://www.uniprot.org/terms.
Distributed under the Creative Commons Attribution-NoDerivs License.
------------------------------------------------------------------------------------------------------------------

Region 1: 1-9 Region 9: 65-85 Region 2: 10-120 Region 3: 121-133 Region 4: 134-191 Region 5: 192-223 Region 6: 224-237 Region 7: 238-293 Region 8: 294-304

Map of ordered and disordered regions







Note: 'Mouse' over a region to see the start and stop residues. Click on a region to see detailed information.


Region 1
Type:Disordered
Name:N-terminal
Location:1 - 9
Length:9
Region sequence:

MAGNFDSEE

Modification type: Native
PDB: 2EYZ:A, 2DVJ:A, 2EYV:A
Structural/functional type: Relationship to function unknown
Functional classes: Modification site
Functional subclasses: Acetylation
Detection methods:
  1. Nuclear magnetic resonance (NMR) (298 K; pH: 6.8; Crk-II (PDB 2EYZ is full-length Crk-II, other PDBs are fragments) 0.4 mM; EDTA 1 mM; DTT 2 mM; NaCl 150 mM; 90% H2O/10% D2O; Phosphate buffer 20 mM)

  2. Small-angle X-ray scattering (SAXS) (298 K; pH: 8; Crk-II 20 mg/mL; NaCl 150 mM; Tris-HCl buffer 20 mM)

References:
  1. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK." Nat. Struct. Mol. Biol.. 2007; 14(6): 503-10. PubMed: 17515907

Comments:
 



Region 2
Type:Ordered
Name:SH2-SH2 domain
Location:10 - 120
Length:111
Region sequence:

RSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGDYVLSVSENSRVSHYIINSSGPRP
PVPPSPAQPPPGVSPSRLRIGDQEFDSLPALLEFYKIHYLDTTTLIEPVSR

Modification type: Native
PDB: 2EYZ:A, 2DVJ:A, 2EYV:A
Structural/functional type: Function arises from the ordered state
Functional classes: Modification site
Molecular recognition effectors
Functional subclasses: Autoregulatory
Protein-protein binding
Intraprotein interaction
Phosphorylation
Detection methods:
  1. Nuclear magnetic resonance (NMR) (298 K; pH: 6.8; 90% H2O/10% D2O; Crk-II (PDB 2EYZ is full-length Crk-II, other PDBs are fragments) 0.4 mM; DTT 2 mM; EDTA 1 mM; NaCl 150 mM; Phosphate buffer 20 mM)

  2. Small-angle X-ray scattering (SAXS) (298 K; pH: 8; Crk-II 20 mg/mL; NaCl 150 mM; Tris-HCl buffer 20 mM)

References:
  1. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK." Nat. Struct. Mol. Biol.. 2007; 14(6): 503-10. PubMed: 17515907

Comments:
 



Region 3
Type:Disordered
Name:linker
Location:121 - 133
Length:13
Region sequence:

SRQGSGVILRQEE

Modification type: Native
PDB: 2EYZ:A, 2DVJ:A, 2EYV:A, 2EYW:A
Structural/functional type: Function arises from the disordered state
Functional classes: Entropic chain
Molecular assembly
Functional subclasses: Intraprotein interaction
Flexible linkers/spacers
Autoregulatory
Detection methods:
  1. Nuclear magnetic resonance (NMR) (298 K; pH: 6.8; Crk-II (PDB 2EYZ is full-length Crk-II, other PDBs are fragments) 0.4 mM; EDTA 1 mM; DTT 2 mM; NaCl 150 mM; 90% H2O/10% D2O; Phosphate buffer 20 mM)

  2. Small-angle X-ray scattering (SAXS) (298 K; pH: 8; Crk-II 20 mg/mL; NaCl 150 mM; Tris-HCl buffer 20 mM)

References:
  1. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK." Nat. Struct. Mol. Biol.. 2007; 14(6): 503-10. PubMed: 17515907

Comments:
 



Region 4
Type:Ordered
Name:nSH3 domain
Location:134 - 191
Length:58
Region sequence:

AEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRGMIPVPYVEKYR

Modification type: Native
PDB: 2EYZ:A, 2DVJ:A, 2EYW:A
Structural/functional type: Function arises from the ordered state
Functional classes: Modification site
Molecular recognition effectors
Functional subclasses: Intraprotein interaction
Phosphorylation
Protein-protein binding
Detection methods:
  1. Nuclear magnetic resonance (NMR) (298 K; pH: 6.8; 90% H2O/10% D2O; Crk-II (PDB 2EYZ is full-length Crk-II, other PDBs are fragments) 0.4 mM; DTT 2 mM; EDTA 1 mM; NaCl 150 mM; Phosphate buffer 20 mM)

  2. Small-angle X-ray scattering (SAXS) (298 K; pH: 8; Crk-II 20 mg/mL; NaCl 150 mM; Tris-HCl buffer 20 mM)

References:
  1. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK." Nat. Struct. Mol. Biol.. 2007; 14(6): 503-10. PubMed: 17515907

Comments:
 



Region 5
Type:Disordered
Name:linker
Location:192 - 223
Length:32
Region sequence:

PASASVSALIGGNQEGSHPQPLGGPEPGPYAQ

Modification type: Native
PDB: 2EYZ:A, 2DVJ:A, 2EYW:A, 2EYX:A
Structural/functional type: Function arises from the disordered state
Functional classes: Modification site
Molecular assembly
Entropic chain
Functional subclasses: Intraprotein interaction
Flexible linkers/spacers
Phosphorylation
Autoregulatory
Detection methods:
  1. Nuclear magnetic resonance (NMR) (298 K; pH: 6.8; 90% H2O/10% D2O; Crk-II (PDB 2EYZ is full-length Crk-II, other PDBs are fragments) 0.4 mM; DTT 2 mM; EDTA 1 mM; NaCl 150 mM; Phosphate buffer 20 mM)

  2. Small-angle X-ray scattering (SAXS) (298 K; pH: 8; Crk-II 20 mg/mL; NaCl 150 mM; Tris-HCl buffer 20 mM)

References:
  1. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK." Nat. Struct. Mol. Biol.. 2007; 14(6): 503-10. PubMed: 17515907

Comments:
 



Region 6
Type:Disordered
Name:Inter-SH3 Core (ISC)
Location:224 - 237
Length:14
Region sequence:

PSVNTPLPNLQNGP

Modification type: Native
PDB: 2DVJ:A, 2EYX:A, 2EYZ:A
Structural/functional type: Function arises via a disorder to order transition
Functional classes: Molecular assembly
Entropic chain
Functional subclasses: Intraprotein interaction
Flexible linkers/spacers
Autoregulatory
Detection methods:
  1. Nuclear magnetic resonance (NMR) (298 K; pH: 6.8; 90% H2O/10% D2O; Crk-II (PDB 2EYZ is full-length Crk-II, other PDBs are fragments) 0.4 mM; DTT 2 mM; EDTA 1 mM; NaCl 150 mM; Phosphate buffer 20 mM)

  2. Small-angle X-ray scattering (SAXS) (298 K; pH: 8; Crk-II 20 mg/mL; NaCl 150 mM; Tris-HCl buffer 20 mM)

References:
  1. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK." Nat. Struct. Mol. Biol.. 2007; 14(6): 503-10. PubMed: 17515907

Comments:
 



Region 7
Type:Disordered
Name:cSH3
Location:238 - 293
Length:56
Region sequence:

IYARVIQKRVPNAYDKTALALEVGELVKVTKINVSGQWEGECNGKRGHFPFTHVRL

Modification type: Native
PDB: 2EYX:A, 2EYZ:A
Structural/functional type: Function arises via a disorder to order transition
Functional classes: Modification site
Molecular assembly
Functional subclasses: Intraprotein interaction
Phosphorylation
Autoregulatory
Detection methods:
  1. Nuclear magnetic resonance (NMR) (298 K; pH: 6.8; 90% H2O/10% D2O; Crk-II (PDB 2EYZ is full-length Crk-II, other PDBs are fragments) 0.4 mM; DTT 2 mM; EDTA 1 mM; NaCl 150 mM; Phosphate buffer 20 mM)

  2. Small-angle X-ray scattering (SAXS) (298 K; pH: 8; Crk-II 20 mg/mL; NaCl 150 mM; Tris-HCl buffer 20 mM)

References:
  1. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK." Nat. Struct. Mol. Biol.. 2007; 14(6): 503-10. PubMed: 17515907

Comments:
 



Region 8
Type:Disordered
Name:C-terminal
Location:294 - 304
Length:11
Region sequence:

LDQQNPDEDFS

Modification type: Native
PDB: 2EYX:A, 2EYZ:A
Structural/functional type: Relationship to function unknown
Functional classes: Unknown
Functional subclasses: Unknown
Detection methods:
  1. Nuclear magnetic resonance (NMR) (298 K; pH: 6.8; 90% H2O/10% D2O; Crk-II (PDB 2EYZ is full-length Crk-II, other PDBs are fragments) 0.4 mM; DTT 2 mM; EDTA 1 mM; NaCl 150 mM; Phosphate buffer 20 mM)

  2. Small-angle X-ray scattering (SAXS) (298 K; pH: 8; Crk-II 20 mg/mL; NaCl 150 mM; Tris-HCl buffer 20 mM)

References:
  1. Kobashigawa Y, Sakai M, Naito M, Yokochi M, Kumeta H, Makino Y, Ogura K, Tanaka S, Inagaki F. "Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK." Nat. Struct. Mol. Biol.. 2007; 14(6): 503-10. PubMed: 17515907

Comments:
 



Region 9
Type:Disordered
Name:DE loop
Location:65 - 85
Length:21
Region sequence:

SGPRPPVPPSPAQPPPGVSPS

Modification type: Fragment
PDB: 1JU5:A
Structural/functional type: Function arises from the disordered state
Functional classes: Modification site
Molecular recognition effectors
Entropic chain
Functional subclasses: Flexible linkers/spacers
Phosphorylation
Protein-protein binding
Detection methods:
  1. Nuclear magnetic resonance (NMR) (303 K; pH: 6.8; 90% H2O/ 10% D2O; Crk SH2 domain fragment (aa S12-R120) (PDB 1JU5) 1.5 mM; sodium azide (0.02%); sodium phosphate 50 mM)

References:
  1. Donaldson LW, Gish G, Pawson T, Kay LE, Forman-Kay JD. "Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide." Proc. Natl. Acad. Sci. U.S.A.. 2002; 99(22): 14053-8. PubMed: 12384576

Comments:
According to Donaldson et al (2002), the "DE loop" is the flexible linker within the SH2-SH2 domain, and the loop contains an Abl SH3 binding site at G66-P75. The loop also contains phosphorylation sites at S74 and S83, according to UniProt.




References

  1. Feller SM, Lewitzky M. "What is in a loop?" Cell Commun. Signal. 2012; 10(1): 31. PubMed: 23110718



Comments


According to Kobashigawa et al (2007), phosphorylation of T221 triggers intramolecular interactions between the SH domains and the hydrophobic Inter-SH3 Core (ISC), resulting in the compact structure of Crk-II. Compare the compact structure of Crk-II with Crk-I [DP00748_A002] which has an extended structure (Crk-I is identical to Crk-II aa 1-203 plus R204 (instead of N204 as in Crk-II)).

Kobashigawa et al (2007) also demonstrated how "amino acid replacement or deletion in the ISC, or disruption of cSH3, disturbs the assembled structure of CRKII."



Feller and Lewitzky (2012) discuss the importance of loops for a variety of protein functions.


If you have any comments or wish to provide additional references to this protein or its disordered region(s), please click here to e-mail us.


Disprot-footer
Contact us